A detailed history of Man Group PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Man Group PLC holds 971,353 shares of GH stock, worth $26.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
971,353
Previous 1,008,046 3.64%
Holding current value
$26.3 Million
Previous $27.3 Million 26.51%
% of portfolio
0.05%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $628,551 - $987,408
-36,693 Reduced 3.64%
971,353 $20 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $8.63 Million - $11.8 Million
400,107 Added 65.81%
1,008,046 $27.3 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $15.3 Million - $23.7 Million
592,224 Added 3768.53%
607,939 $18 Million
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $3.46 Million - $6.27 Million
-165,033 Reduced 91.31%
15,715 $562,000
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $4.14 Million - $6.1 Million
180,748 New
180,748 $4.24 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $3.08 Million - $8.28 Million
107,026 Added 301.53%
142,520 $5.75 Million
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $1.71 Million - $3.57 Million
35,494 New
35,494 $2.35 Million
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $2.02 Million - $2.75 Million
-22,794 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $1.77 Million - $2.36 Million
-17,878 Reduced 43.96%
22,794 $2.85 Million
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $1.19 Million - $1.79 Million
-10,832 Reduced 21.03%
40,672 $5.05 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $469,793 - $662,311
3,698 Added 7.74%
51,504 $7.86 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $1.34 Million - $1.82 Million
13,422 Added 39.04%
47,806 $6.16 Million
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $854,926 - $1.19 Million
-10,644 Reduced 23.64%
34,384 $3.84 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $2.46 Million - $3.96 Million
40,599 Added 916.66%
45,028 $3.65 Million
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $261,488 - $393,339
4,429 New
4,429 $308,000
Q4 2019

Feb 18, 2020

SELL
$59.49 - $82.78 $453,908 - $631,611
-7,630 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $129,310 - $227,879
2,066 Added 37.13%
7,630 $488,000
Q2 2019

Aug 14, 2019

SELL
$63.94 - $91.11 $195,272 - $278,249
-3,054 Reduced 35.44%
5,564 $480,000
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $295,597 - $844,391
8,618 New
8,618 $661,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.77B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.